Search Results Search Sort by RelevanceMost Recent State of the Art and Science Dec 2003 Identifying an Impaired Physician Stephen Ross, MD Physicians who suspect a colleague might have a substance use disorder can intervene in various ways in order to help facilitate recovery. Virtual Mentor. 2003;5(12):568-571. doi: 10.1001/virtualmentor.2003.5.12.cprl1-0312. Podcast Jul 2024 Author Interview: “How Should Risks and Benefits of Short-Acting Opioids Be Evaluated in the Care of Inpatients With OUD?” Dr Katherin M. Duthie joins Ethics Talk to discuss her article, coauthored with Dr Kathryn A. Dong: “How Should Risks and Benefits of Short-Acting Opioids Be Evaluated in the Care of Inpatients With OUD?” Case and Commentary Sep 2002 An Impaired Resident, Commentary 1 Erin Egan, MD, JD Physicians and physicians-in-training have a responsibility to speak up if they feel a medical colleague's impairment puts patients at risk. Virtual Mentor. 2002;4(9):256-259. doi: 10.1001/virtualmentor.2002.4.9.ccas1-0209. Case and Commentary Sep 2002 An Impaired Resident, Commentary 2 DeWitt C. Baldwin, Jr, MD Physicians and physicians-in-training have a responsibility to speak up if they feel a medical colleague's impairment puts patients at risk. Virtual Mentor. 2002;4(9):260-263. doi: 10.1001/virtualmentor.2002.4.9.ccas1-0209. Viewpoint Sep 2002 The Secret Ingredient Colleen Danz Little-known facts about food allergens, allergies, and labeling. Virtual Mentor. 2002;4(9):275-276. doi: 10.1001/virtualmentor.2002.4.9.dykn1-0209. Case and Commentary Jul 2024 How Should Risks and Benefits of Short-Acting Opioids Be Evaluated in the Care of Inpatients With OUD? Kathryn A. Dong, MD, MSc and Katherine M. Duthie, PhD, HEC-C Severe withdrawal, risk of patient-initiated discharge, and some inpatients’ uses of substances prompt questions considered in this commentary. AMA J Ethics. 2024;26(7):E512-519. doi: 10.1001/amajethics.2024.512. Pagination First page « First Previous page ‹ Previous … Page 9 Page 10 Page 11 Page 12 Page 13 Page 14 Page 15 Page 16 Current page 17
State of the Art and Science Dec 2003 Identifying an Impaired Physician Stephen Ross, MD Physicians who suspect a colleague might have a substance use disorder can intervene in various ways in order to help facilitate recovery. Virtual Mentor. 2003;5(12):568-571. doi: 10.1001/virtualmentor.2003.5.12.cprl1-0312.
Podcast Jul 2024 Author Interview: “How Should Risks and Benefits of Short-Acting Opioids Be Evaluated in the Care of Inpatients With OUD?” Dr Katherin M. Duthie joins Ethics Talk to discuss her article, coauthored with Dr Kathryn A. Dong: “How Should Risks and Benefits of Short-Acting Opioids Be Evaluated in the Care of Inpatients With OUD?”
Case and Commentary Sep 2002 An Impaired Resident, Commentary 1 Erin Egan, MD, JD Physicians and physicians-in-training have a responsibility to speak up if they feel a medical colleague's impairment puts patients at risk. Virtual Mentor. 2002;4(9):256-259. doi: 10.1001/virtualmentor.2002.4.9.ccas1-0209.
Case and Commentary Sep 2002 An Impaired Resident, Commentary 2 DeWitt C. Baldwin, Jr, MD Physicians and physicians-in-training have a responsibility to speak up if they feel a medical colleague's impairment puts patients at risk. Virtual Mentor. 2002;4(9):260-263. doi: 10.1001/virtualmentor.2002.4.9.ccas1-0209.
Viewpoint Sep 2002 The Secret Ingredient Colleen Danz Little-known facts about food allergens, allergies, and labeling. Virtual Mentor. 2002;4(9):275-276. doi: 10.1001/virtualmentor.2002.4.9.dykn1-0209.
Case and Commentary Jul 2024 How Should Risks and Benefits of Short-Acting Opioids Be Evaluated in the Care of Inpatients With OUD? Kathryn A. Dong, MD, MSc and Katherine M. Duthie, PhD, HEC-C Severe withdrawal, risk of patient-initiated discharge, and some inpatients’ uses of substances prompt questions considered in this commentary. AMA J Ethics. 2024;26(7):E512-519. doi: 10.1001/amajethics.2024.512.